PRODUCTS
« BACK TO "INTERNATIONAL"
Risedronate is a bisphosphonate which binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption.
Risedronate is indicated for the treatment of postmenopausal osteoporosis and the reduction of the risk of vertebral fractures.
| Active ingredient | Pharmaceutical form | Package | Therapeutic target |
|
|
|
|